Report #2889420

Received Mar 17, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 1.3 yrs
State: CO
Recovered: Recovered
Vaccinated: Mar 5, 2026
Onset: Mar 5, 2026
Days to onset: 0
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTPPVHBHPB	DTAP+IPV+HIB+HEPB (VAXELIS)	MSP VACCINE COMPANY	2	u8372aa	IM / LL
PNC20	PNEUMO (PREVNAR20)	PFIZER\WYETH	2	mh1445	IM / RL
RV5	ROTAVIRUS (ROTATEQ)	MERCK & CO. INC.	2	2155634	PO / MO

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

RotaTeq was inadvertently administered outside the approved age range (maximum age for final dose is 8 months). Mother was informed immediately of the error. Based on VAERS safety data from 2006-2019, no unexpected adverse events have been identified when rotavirus vaccines are inadvertently given to children =8 months of age. The primary theoretical concern is intussusception as it is with any child receiving RotaTeq, though risk is low at this age.

Current illness

Eczema

Medical history

none

Other medications

Hydrocortisone 2.5% topical ointment

Allergies

NKDA

Lab data

n/a